Diabetic Retinopathy Predicts All-Cause Mortality and Cardiovascular Events in Both Type 1 and 2 Diabetes: Meta-analysis of observational studies

by Kramer, Caroline K., Rodrigues, Ticiana C., Canani, Luis H., Gross, Jorge L., Azevedo, Mirela J.
Published 2011

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

by Bailey, Clifford J, Gross, Jorge L, Hennicken, Delphine, Iqbal, Nayyar, Mansfield, Traci A, List, James F
Published 2013

Evidence-based clinical use of insulin premixtures

by Tambascia, Marcos Antônio, Nery, Márcia, Gross, Jorge Luiz, Ermetice, Mariana Narbot, de Oliveira, Carolina Piras
Published 2013

Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

by Bailey, Clifford J, Gross, Jorge L, Hennicken, Delphine, Iqbal, Nayyar, Mansfield, Traci A, List, James F
Published 2013

Thyroid Ultrasound Features and Risk of Carcinoma: A Systematic Review and Meta-Analysis of Observational Studies

by Remonti, Luciana Reck, Kramer, Caroline Kaercher, Leitão, Cristiane Bauermann, Pinto, Lana Catani F., Gross, Jorge Luiz
Published 2015

The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials

by Varvaki Rados, Dimitris, Catani Pinto, Lana, Reck Remonti, Luciana, Bauermann Leitão, Cristiane, Gross, Jorge Luiz
Published 2016

Correction: The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials

by Rados, Dimitris Varvaki, Pinto, Lana Catani, Remonti, Luciana Reck, Leitão, Cristiane Bauermann, Gross, Jorge Luiz
Published 2016

The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone

by DeFronzo, Ralph A., Hissa, Miguel N., Garber, Alan J., Luiz Gross, Jorge, Yuyan Duan, Raina, Ravichandran, Shoba, Chen, Roland S.
Published 2009

Ethnic Differences in Glycemic Markers in Patients With Type 2 Diabetes

by Wolffenbuttel, Bruce H.R., Herman, William H., Gross, Jorge L., Dharmalingam, Mala, Jiang, Honghua H., Hardin, Dana S.
Published 2013

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial

by Schernthaner, Guntram, Gross, Jorge L., Rosenstock, Julio, Guarisco, Michael, Fu, Min, Yee, Jacqueline, Kawaguchi, Masato, Canovatchel, William, Meininger, Gary
Published 2013

Glucose tolerance status is a better predictor of diabetes and cardiovascular outcomes than metabolic syndrome: a prospective cohort study

by Furtado de Souza, Camila, Dalzochio, Mériane Boeira, de Oliveira, Francisco Jorge Arsego, Gross, Jorge Luiz, Leitão, Cristiane Bauermann
Published 2012

The Catalase –262C/T Promoter Polymorphism and Diabetic Complications in Caucasians with Type 2 Diabetes

by dos Santos, Kátia Gonçalves, Canani, Luís Henrique, Gross, Jorge Luiz, Tschiedel, Balduíno, Souto, Kátia Elisabete Pires, Roisenberg, Israel
Published 2006

Efficacy of SGLT2 inhibitors in glycemic control, weight loss and blood pressure reduction: a systematic review and meta-analysis

by Pinto, Lana Catani, Rados, Dimitris Varvaki, Remonti, Luciana Reck, Kramer, Caroline Kaercher, Leitao, Cristiane Bauermann, Gross, Jorge Luiz
Published 2015

Endothelin-1 gene polymorphisms and diabetic kidney disease in patients with type 2 diabetes mellitus

by Zanatta, Claudete M., Crispim, Daisy, Sortica, Denise A., Klassmann, Lucas P., Gross, Jorge L., Gerchman, Fernando, Canani, Luís H.
Published 2015

Fiber intake and inflammation in type 1 diabetes

by Bernaud, Fernanda S R, Beretta, Mileni Vanti, do Nascimento, Cigléa, Escobar, Fabrícia, Gross, Jorge L, Azevedo, Mirela J, Rodrigues, Ticiana C
Published 2014

A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus

by Pan, Changyu, Gross, Jorge L., Yang, Wenying, Lv, Xiaofeng, Sun, Li, Hansen, Charlotte Thim, Xu, Hongfei, Wagner, Robert
Published 2016

A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, in treatment o...

by Gross, Jorge Luiz, Rogers, James, Polhamus, Daniel, Gillespie, William, Friedrich, Christian, Gong, Yan, Monz, Brigitta Ursula, Patel, Sanjay, Staab, Alexander, Retlich, Silke
Published 2013

Cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients with peripheral artery disease

by Canani, Luís Henrique, Copstein, Eduardo, Pecis, Miriam, Friedman, Rogério, Leitão, Cristiane Bauermann, Azevedo, Mirela Jobim, Triches, Cristina, Rados, Dimitris Rucks Varvaki, Moreas, Ruy Silveira, Gross, Jorge Luiz
Published 2013

Hypertension management algorithm for type 2 diabetic patients applied in primary care

by Viana, Luciana V, Leitão, Cristiane B, Grillo, Maria F, Rocha, Ennio P C C, Brenner, Juliana K, Friedman, Rogerio, Gross, Jorge L
Published 2013

Are diabetes management guidelines applicable in ‘real life’?

by Viana, Luciana V, Leitão, Cristiane B, Grillo, Maria de Fátima, Rocha, Ennio P C C, Brenner, Juliana K, Friedman, Rogério, Gross, Jorge L
Published 2012